Jarvis.Infecciones hospitalarias_7ed.

Capítulo 1 • Epidemiología de las infecciones relacionadas con la asistencia sanitaria 17

REFERENCIAS

30. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol . 2003;24:362-386. 31. Ostrowsky B, Steinberg JT, Farr B, et al. Reality check: should we try to detect and isolate vancomycin-resistant enterococci patients? Infect Control Hosp Epidemiol . 2001;22:116-119. 32. Centers for Disease Control and Prevention. Containment strategy guidelines. Interim guidance for a public health response to contain novel or targeted multidrug-resistant organisms (MDROs). Acceso en enero de 2019. https://www.cdc.gov/hai/pdfs/contain ment/Health-Response-Contain-MDRO-H.pdf 33. Morgan D, Pineles L, Shardell M, et al. The effect of contact precautions on healthcare worker activity in acute care hospitals. Infect Control Hosp Epidemiol . 2013;34:69-73. 34. Sherertz RJ, Bassetti S, Bassetti-Wyss B. “Cloud” health-care workers. Emerg Infect Dis . 2001;7:241-244. 35. Beck-Sague C, Jarvis WR, Martone WJ. Outbreak investigations. Infect Control Hosp Epide miol . 1997;18:138-145. 36. Emori TG, Culver DH, Horan TC, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control . 1991;19:19-35. 37. Horan TC, Gaynes RP. Surveillance of nosocomial infections. En: Mayhall CG, ed. Hospital Epidemiology and Infection Control . Lippincott Williams & Wilkins; 2004:1659-1702. 38. Centers for Disease Control and Prevention. National Healthcare Safety Network. http:// www.cdc.gov/nhsn/about.html 39. Centers for Disease Control and Prevention. 2019 National and State Healthcare–Associated Infections Progress Report . Acceso el 2 de diciembre de 2020. https://www.cdc.gov/hai/data/ portal/progress-report.html#2018 40. Centers for Disease Control and Prevention, National Healthcare Safety Network. Antimicrobial use and resistance module. https://www.cdc.gov/nhsn/pdfs/pscmanual/ 11pscaurcurrent.pdf 41. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. CDC guideline for the prevention of surgical site infection, 2017 . JAMA Surg. 2017;152:784-791. 42. Jarvis WR. Nosocomial outbreaks: the Centers for Disease Control’s Hospital Infections Program experience, 1980 to 1990. Epidemiology Branch, Hospital Infections Program. Am J Med . 1991;91:101S-106S. 43. Jarvis WR. Hospital Infections Program, Centers for Disease Control and Prevention on-site outbreak investigations, 1990 to 1999. Semin Infect Control . 2001;1:73-84. 44. David M, Daum R, Bayer A, et al. Staphylococcus aureus bacteremia at five US academic medical centers, 2008-2011: significant geographic variation in community-onset infec tions. Clin Infect Dis . 2014;59:798-807. 45. Tafuro P, Ristuccia P. Recognition and control of outbreaks of nosocomial infections in the intensive care setting. Heart Lung . 1984;13:486-495. 46. McDonald L, Killgore G, Thompson A, et al. An epidemic, toxin gene–variant strain of Clostridium difficile . N Engl J Med . 2005;353:2433-2441. 47. Gregg MB, Dicker RC, Goodman RA. Field Epidemiology . Oxford University Press; 1996. 48. Centers for Disease Control and Prevention. Principles of Epidemiology in Public Health Prac tice . 3rd ed. CDC; 2012. https://www.cdc.gov/csels/dsepd/ss1978/ss1978.pdf 49. Christensen B, Fagan R. Healthcare settings. The CDC Field Epidemiology Manual. https://www.cdc.gov/eis/field-epi-manual/chapters/Healthcare-Settings.html 50. Centers for Disease Control and Prevention. Healthcare-associated infection (HAI) out break investigation toolkit. https://www.cdc.gov/hai/outbreaks/outbreaktoolkit.html 51. Rothman KS, Greenland S. Measures of disease frequency. En: Rothman KJ, Greenland S, eds. Modern Epidemiology . Lippincott-Raven; 1998:29-46. 52. Freeman J. Quantitative epidemiology. En: Herwaldt LA, Decker MD, eds. The Society for Healthcare Epidemiology of America—A Practical Handbook for Hospital Epidemiologists . Slack; 1998:205-213. 53. Gerber J. Epidemiologic methods in infection control. En: Lautenbach E, Malani P, Woeltje KF, Society for Healthcare Epidemiology of America, eds. Practical Healthcare Epide miology. 4th ed. University of Chicago Press; 2018. 54. Brawley RL, Weber DJ, Samsa GP, et al. Multiple nosocomial infections: an incidence study. Am J Epidemiol . 1989;130:769-780. 55. Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavi rus emerging in China—key questions for impact assessment. N Engl J Med. 2020;382: 692-694. 56. Edwards JE. Candida species. En: Mandell GL, Douglas RG, Bennett JE, et al, eds. Man dell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases . Churchill Livingstone; 2000:2656-2674. 57. McDonald LC, Banerjee SN, Jarvis WR. Seasonal variation of acinetobacter infections: 1987-1996: nosocomial infections surveillance system. Clin Infect Dis . 1999;29:1133-1137. 58. Gross PA. Basics of stratifying for severity of illness. Infect Control Hosp Epidemiol . 1996; 17:675-686. 59. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk predic tion of hospital mortality for critically ill hospitalized adults. Chest . 1991;100:1619-1636. 60. Furnival RA, Schunk JE. ABCs of scoring systems for pediatric trauma. Pediatr Emerg Care . 1999;15:215-223. 61. Richardson DK, Corcoran JD, Escobar GJ, et al. SNAP-II and SNAPPE-II: simplified new born illness severity and mortality risk scores. J Pediatr . 2001;138:92-100. 62. Harris AD, Samore MH, Lipsitch M, et al. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa , Enterococci, and Escherichia coli . Clin Infect Dis . 2002;34:1558-1563. 63. Ostrowsky B, Jarvis WR. Efficient management of outbreak investigations. En: Wen zel RP, ed. Prevention and Control of Nosocomial Infections . Lippincott Williams & Wilkins; 2003:500-523. 64. Wenzel RP, Thompson RL, Landry SM, et al. Hospital-acquired infections in intensive care unit patients: an overview with emphasis on epidemics. Infect Control . 1983:4371-4375. 65. Chung P, Currie B, Guo Y. An investigation to identify a resource efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection. Am J Infect Control . 2014;42:S264-S268.

1. Brachman PS. Epidemiology of nosocomial infections. En: Bennett JV, Brachman PS, eds. Hospital Infections . Lippincott-Raven; 1998:3-16. 2. Schoenbach VJ, Rosamond WD. Understanding the Fundamentals of Epidemiology: An Evolving Text . Department of Epidemiology, School of Public Health, University of North Carolina; 2000. http://www.epidemiolog.net/evolving/TableOfContents.htm 3. Harvard School of Public Health, Department of Epidemiology. https://www.hsph.harvard. edu/epidemiology/ 4. Centers for Disease Control and Prevention. Healthcare-associated infections. https:// www.cdc.gov/hai/index.html 5. Magill SS, O’Leary E, Janelle SJ, et al. Changes in prevalence of health care–associated in fections in U.S. Hospitals. N Engl J Med . 2018;379:1732-1744. https://www.nejm.org/doi/ full/10.1056/NEJMoa1801550 6. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2019 . U.S. Department of Health and Human Services, CDC; 2019. Acceso en diciembre de 2019. www.cdc.gov/DrugResistance/Biggest-Threats.html 7. Burke JP. Infection control—a problem for patient safety. N Engl J Med . 2003;348:651-656. 8. Schreiber PW, Sax H, Wolfensberger A, et al. The preventable proportion of healthcare associated infections 2005-2016: systematic review and meta-analysis. Infect Control Hosp Epidemiol . 2018;39:1277-1295. 9. Burton D, Edwards J, Horan T, et al. Methicillin-resistant Staphylococcus aureus central line– associated bloodstream infections in U.S. intensive care units, 1997-2007. J Am Med Assoc . 2009;301:727-736. 10. Yokoe D, Anderson D, Berenholtz SM, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol . 2014;35:967-977. 11. Centers for Disease Control and Prevention. Core infection prevention and control prac tices for safe healthcare delivery in all settings—recommendations of the Healthcare Infection Control Practices Advisory Committee. https://www.cdc.gov/hicpac/pdf/core practices.pdf 12. Centers for Disease Control and Prevention. Guidelines for prevention and control of HAI in partnership with Healthcare Infection Control Practices Advisory Committee. Acceso el 8 de marzo de 2021. https://www.cdc.gov/hicpac/index.html 13. Gould C, McDonald CL. Review bench-to-bedside review: Clostridium difficile colitis. Crit Care. 2008;12:203. https://doi.org/10.1186/cc6207 14. McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis . 2018;66:e1-e48. 15. Dellit T, Owen R, McGowan J, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for developing an institutional pro gram to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-177. 16. Moody J, Cosgrove S, Olmstead R, et al. APIC/SHEA position paper antimicrobial stewardship: a collaborative partnership between infection preventionists and healthcare epidemiologists. Infect Control Hosp Epidemiol. 2012;33:328-330. 17. McKibben L, Horan T, Tokars JI, et al. Guidance on public reporting of healthcare associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am J Infect Control. 2005;33:217-226. 18. Wong ES, Rupp ME, Mermel L, et al. Public disclosure of healthcare-associated infections: the role of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epide miol . 2005;26:210-212. 19. Centers for Medicare and Medicaid Services, HHS. Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Fed Regist . 2007;72:47129-48175. 20. Centers for Medicare and Medicaid Services, HHS. Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year 2009 rates; payment for graduate medical education in certain emergency situations; changes to disclosure of phy sician ownership in hospitals and physician self-referral rules, updates to the long term care prospective payment system; updates to certain IPPS-excluded hospitals; and collec tion of information regarding financial relationships between hospitals. Final rules. Fed Regist . 2008;73:48433-49084. 21. Centers for Disease Control and Prevention. States with HAI reporting mandates. Acceso el 13 de noviembre de 2019. https://www.cdc.gov/HAI/state-based/required-to-report-hai NHSN.html 22. Association for Professionals in Infection Control and Epidemiology. Eliminating HAIs. Acceso el 9 de marzo de 2021. https://cqrcengage.com/apic/HAIs 23. Centers for Disease Control and Prevention. Epidemiology and Laboratory Capacity (ELC) HAI/AR program funded activities. Acceso el 3 de febrero de 2021. https://www. cdc.gov/hai/state-based/funded-activities.html 24. Lautenbach E, Saint S, Henderson DK, Harris AD. Initial response of health care institu tions to emergence of H1N1 influenza: experiences, obstacles, and perceived future needs. Clin Infect Dis . 2010;50:523-527. 25. Banach D, Johnston B, Al-Zubeidi D, et al. Outbreak response and incident management: SHEA guidance and resources for healthcare epidemiologists in United States acute-care hospitals. Infect Control Hosp Epidemiol . 2017;38:1393-1419. 26. Mody L, Akinboyo IC, Babcock HM, et al. COVID-19 research agenda for healthcare epi demiology. Infect Control Hosp Epidemiol . 2022;43:156-166. 27. Relman DA, Falkow S. Microbial virulence factors. En: Mandell GL, Douglas RG, Bennett JE, et al, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases . Churchill Livingstone; 2000:2. 28. Jarvis WR. The epidemiology of colonization. Infect Control Hosp Epidemiol . 1996;17:47-52. 29. Jarvis WR, Ostrowsky B. Dinosaurs, methicillin-resistant Staphylococcus aureus , and infection control personnel: survival through translating science into prevention. Infect Control Hosp Epidemiol . 2003;24:392-396.

Copyright © 2024 Wolters Kluwer, Inc. Unauthorized reproduction of the content is prohibited.